Evidence map›Paper›PMID 38294522›Full record

ArticlePediatric nephrology (Berlin, Germany)2024

New insights from the genetic work-up in early onset nephrotic syndrome: report from a registry in western India.

Jyoti Sharma, Anshuman Saha, Alpana Ohri, Vaishali More, Fagun Shah, Jalpa Dave, Brinda Panchal Jain, Manoj Matnani, K Sathe, Pankaj Bhansali and 9 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jyoti SharmaKEM Hospital, Pune, India. jyotivsharma@gmail.com.ORCID 0000-0001-7054-2647
Anshuman SahaIKDRC-ITS-GUTS, Ahmedabad, India.
Alpana OhriB J Wadia Hospital for Children, Mumbai, India.
Vaishali MoreTara Children's Kidney Care, Wockhardt Hospital and SRCC Children's Hospital, Mumbai, India.
Fagun ShahChild's Kidney Care Centre, Surat, India.
Jalpa DaveTender Kidney Care, Vadodara, India.
Brinda Panchal JainNamaha Hospital, Kandivali and Thunga Hospital, Malad, Mumbai, India.
Manoj MatnaniJehangir Hospital, Pune, India.
K SatheSir HN Reliance Foundation Hospital and Research Centre, Mumbai, India.
Pankaj BhansaliOrchid Pediatric Superspeciality Clinic, Aurangabad, India.
Puneet Chhajed, Malad, Mumbai, India.
Pawan Deore, Nashik, India.
Nivedita PandeBYL Nair Hospital, Mumbai, India.
Chintan ShahDivision of Pediatric Nephrology, B J Wadia Hospital for Children, Mumbai, India.
Vala KinnariIKDRC-ITS-GUTS, Ahmedabad, India.
Jyoti SinghalKEM Hospital, Pune, India.
Nisha KrishnamurthySRCC Children's Hospital, Mumbai, India.
Meenal AgarwalKEM Hospital, Pune, India.
Uma AliSRCC Children's Hospital, Mumbai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEighty-five percent of infants with congenital nephrotic syndrome (CNS) and 66% with infantile NS (INS) are likely to have a monogenic etiology. There exists a significant genetic variability between different regions and ethnic groups. This study aimed to determine the genetic defects in children with CNS and INS by establishing a registry in western India.

methodsIn this cross-sectional study, pediatric nephrologists from 13 private and government institutions shared relevant clinical data and details of the genetic evaluation of children presenting with NS within the first year of life.

resultsThe median age at presentation was 9 months (range 1-23, IQR 3-13 months), history of consanguinity between parents existed in 14 patients (34%), family history of similar illness in 6 (15%), and extra-renal manifestations in 17 (41%). Twenty-five (61%) were confirmed to have a monogenic etiology. NPHS1 gene was the most implicated (9/25) followed by PLCE1 (5/25). There were 12 variants of uncertain significance (VUS) involving 10 genes (10/25, 40%), and no definite genetic abnormality was found in 4 (25%). A re-analysis of these VUS attempted 2-3 years later facilitated reclassification of 7/12 (58%); increasing the diagnostic yield from 61 to 68.2%.

conclusionsConsistent with worldwide data, variants in NPHS1 gene were the most common cause of NS in infancy; however, PLCE1 was implicated more frequently in our cohort. NUP93 and COL4A3 were reported in early onset NS for the first time. Reclassification of VUS should be attempted, if feasible, since it may lead to a useful revision of diagnosis.

Indexed as

Nephrotic SyndromeRegistriesAge of OnsetCross-Sectional StudiesFemaleGenetic Predisposition to DiseaseGenetic TestingHumansIndiaInfantMaleMembrane ProteinsMembrane ProteinsnephrinCongenital nephrotic syndromeInfantile nephrotic syndromeMolecular testing in NSVariants of uncertain

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.